Cite

HARVARD Citation

    Rol, N. et al. (2019). Nintedanib improves cardiac fibrosis but leaves pulmonary vascular remodelling unaltered in experimental pulmonary hypertension. Cardiovascular research. 115 (2), pp. 432-439. [Online]. 
  
Back to record